SENIOR VICE PRESIDENT
Pharmaceutical Commercialization

My specialty is developing and communicating health economic and outcomes research evidence, pricing strategies, and interacting with medical affairs professionals and payers for over 30 years across a wide range of therapeutic areas. Specific expertise in advanced therapies having supported > 30 cell and gene therapies including 10 that have been approved on the market.

VICE PRESIDENT
Pharmaceutical Commercialization

My specialty is in health economic modeling and value demonstration. With over 20 years of experience, I lead teams to develop robust, rigorous and evidence-based health economic models for pharmaceutical, biopharmaceutical, diagnostic, and medical device companies. My expertise spans a wide range of therapeutic areas including rare diseases and gene therapies. I am committed to partnering with clients to ensure their products demonstrate value and achieve success. 

VICE PRESIDENT
Pharmaceutical Commercialization

My specialty is in developing and disseminating evidence that advances access for emerging therapies. I bring over 30 years in health economics and outcomes research, data analytics, and therapy commercialization to projects that quantify product value for multiple stakeholders. I work across therapeutic areas, including rare and ultra rare, neglected, and prevalent indications. As a partner, I  work collaboratively with clients to develop and implement robust solutions that address their strategic needs.